SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

MullenArmy crypto is trending amidst strong community skepticism, as many investors who experienced significant losses with the original Mullen Automotive stock now view the new token on the Solana network as another potential 'scam,' while a smaller group of 'Mullenaires' actively promotes it.

MKS, Inc. provides instruments, systems, subsystems and process control solutions to measure, control, power, monitor, and analyze parameters of manufacturing processes to improve process performance and productivity for its customers. It operates through the following segments: VSD (Vacuum Solutions Division), PSD (Photonics Solutions Division), and MSD (Materials Solutions Division). The VSD segment delivers foundational technology solutions to semiconductor manufacturing, electronics and packaging and specialty industrial applications. The PSD Segment provides a range of instruments, components and subsystems to edge semiconductor manufacturing, electronics and packaging and specialty industrial applications. The MSD segment develops process and manufacturing technologies for advanced surface modification, electroless and electrolytic plating, and surface finishing. The company was founded in 1961 and is headquartered in Andover, MA.

MKS Inc.

MKS Instruments, Inc.

MKS Instruments is trending as investors digest a mixed earnings report, where an EPS miss was overshadowed by strong revenue growth and optimistic guidance, reinforcing its position as a key enabler in the expanding AI and semiconductor capital equipment sector. The community is actively discussing its significant role in data center buildout and next-generation manufacturing, viewing it as an attractive long-term play despite some technical signals suggesting caution and recent convertible note offerings.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR Protocol is trending due to growing institutional interest, including a Grayscale Trust filing and a major treasury acquisition by SovereignAI, alongside its enhanced cross-chain interoperability via 'Intents' and deepening integration with AI through a partnership with NVIDIA. The community is actively accumulating, viewing NEAR as a leading AI-native blockchain with significant long-term potential amid its recent tokenomics adjustments and utility advancements.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy (SWEAT CRYPTO) is trending with community members debating its potential for a significant price rebound following a period of low valuation. Discussions highlight its move-to-earn utility, where users earn crypto for physical activity, prompting some to consider current prices as a long-term buying opportunity.

ProShares Trust - ProShares Short Bitcoin ETF

ProShares Short Bitcoin Strategy ETF

Heightened community discussion around recently resurfaced Jeffrey Epstein files, which some claim expose links to Bitcoin's early funding, is driving strong bearish sentiment and calls to short the cryptocurrency via BITI. This narrative fuels widespread speculation that Bitcoin is fundamentally flawed and poised for a significant decline.

Viavi Solutions, Inc. engages in the provision of network test, monitoring, and assurance solutions for communications service providers, enterprises, network equipment manufacturers, government and avionics. It operates through the following segments: Network and Service Enablement, and Optical Security and Performance. The Network and Service Enablement segment provides an integrated portfolio of testing, monitoring, assurance and security solutions to help build, maintain and optimize telecom and datacom networks. The Optical Security and Performance segment leverages its core optical coating technologies and volume manufacturing capability to design, manufacture and sell technologies for the anti-counterfeiting, 3D sensing, government and aerospace, automotive and industrial markets. The company was founded in 1979 and is headquartered in Chandler, AZ.

Viavi Solutions Inc

Viavi Solutions is trending after reporting strong quarterly earnings and providing optimistic guidance, driven by robust demand in AI infrastructure, 5G, and data center markets. The company is seeing positive community sentiment and notable analyst upgrades, reflecting its position as a key infrastructure supplier in the evolving telecom sector.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following robust Phase 2 axSpA clinical trial results for sonelokimab, described by the community as potentially "best-in-class" and generating significant buzz ahead of its Investor Day, amplifying discussions around substantial short interest and potential major acquisition interest.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is actively discussed as its acquisition of Astria Therapeutics completes, integrating the late-stage HAE therapy navenibart into its pipeline just before upcoming earnings and new clinical data presentations. Community sentiment is mixed, balancing optimism for the strengthened rare disease portfolio against concerns over stock performance, perceived dilution, and significant short interest.

DRDGOLD Ltd. engages in the business of retreatment of surface gold. The company was founded on February 16, 1895, and is headquartered in Johannesburg, South Africa.

DRDGold Ltd. - ADR

DRDGOLD Ltd.

DRDGOLD is generating significant buzz due to its robust financial performance, highlighted by strong earnings growth and an increased dividend. This is further buoyed by positive analyst sentiment and community discussions focusing on its technical strength and position as a top gold miner in a favorable market for the yellow metal.

TELUS Corp. is a telecommunications company, which engages in the provision of telecommunication services and products primarily for wireless and wireline voice and data. It operates through TELUS Technology Solutions (TTech) and Digitally-led Customer Experiences–TELUS International (DLCX) segments. The TTech segment includes network revenues and equipment sales arising from mobile technologies, data revenues, healthcare software and technology solutions, voice and other telecommunications services revenues, and equipment sales. The DLCX segment is composed of digital customer experience and digital-enablement transformation solutions, including artificial intelligence and content management solutions, provided by TELUS International. The company was founded on October 4, 1990 and is headquartered in Vancouver, Canada.

Telus Corp.

Telus Corp. is trending amid intense debate over the sustainability of its dividend and the perception of an overly high payout ratio, with analyst downgrades adding to investor caution. Community conversations also focus on the company's debt management and the effectiveness of its AI and digital strategy within the Canadian telecom sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Isthmus Partners LLC Acquires 16,505 Shares of Haemonetics Corporation $HAE

Isthmus Partners LLC lifted its holdings in shares of Haemonetics Corporation (NYSE:HAE - Free Report) by 36.5% in the 3rd quarter, according to the company in its most recent disclosure with the...

Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference

Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference PR Newswire BOSTON, Feb...

Haemonetics Corporation (NYSE:HAE) Given Average Rating of "Moderate Buy" by Brokerages

Haemonetics Corporation (NYSE:HAE - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the eleven analysts that are presently covering the firm, Marketbeat.com...

Haemonetics Corporation $HAE Stock Holdings Lessened by Heartland Advisors Inc.

Heartland Advisors Inc. reduced its stake in shares of Haemonetics Corporation (NYSE:HAE - Free Report) by 38.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with...

ABN Amro Investment Solutions Buys Shares of 200,000 Haemonetics Corporation $HAE

ABN Amro Investment Solutions purchased a new position in Haemonetics Corporation (NYSE:HAE - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the...

Short Interest in Haemonetics Corporation (NYSE:HAE) Decreases By 21.7%

Haemonetics Corporation (NYSE:HAE - Get Free Report) was the target of a significant drop in short interest in the month of January. As of January 30th, there was short interest totaling 2,411,300...

Haemonetics Corporation $HAE Shares Sold by Principal Financial Group Inc.

Principal Financial Group Inc. reduced its stake in Haemonetics Corporation (NYSE:HAE - Free Report) by 11.6% during the 3rd quarter, according to the company in its most recent filing with the SEC...

Skylands Capital LLC Has $3.97 Million Stock Holdings in Haemonetics Corporation $HAE

Skylands Capital LLC grew its position in Haemonetics Corporation (NYSE:HAE - Free Report) by 195.4% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 81,369 shares...

Haemonetics (HAE) International Revenue Performance Explored

Evaluate Haemonetics' (HAE) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.

Why Haemonetics (HAE) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.

HAE
Haemonetics Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest HAE News

HAEHaemonetics Corp.